Table 3.
The acquired parameters were tested for significant differences among the healthy and asthma subjects, and also for change with age. Note: Significant differences are displayed in bold font-type.
| Comparison | Healthy vs. Asthma | Young. vs. Old | ||
|---|---|---|---|---|
|
| ||||
| Young | Old | Healthy | Asthma | |
| PFTs | ||||
| FEV1% | 0.014 | 0.065 | 0.15 | 0.36 |
| FVC% | 0.069 | 0.22 | 0.24 | 0.36 |
| FEV1/FVC | 0.041 | 0.20 | 0.14 | 0.045 |
| FEF25-75% | 0.031 | 0.12 | 0.36 | 0.30 |
| RV/TLC | 0.014 | 0.042 | 0.020 | 0.018 |
| DLCO mmol CO | 0.060 | 0.16 | 0.37 | 0.42 |
| FeNO ppb | 0.036 | 0.10 | 0.42 | 0.57 |
| Eos Sputum % | 0.80 | 0.091 | 0.063 | 0.45 |
| HP 129Xe MRI | ||||
| Average VDP | 0.031 | 0.13 | 0.05 | 0.016 |
FEV1%=forced expiratory volume in 1 second; FVC%=forced vital capacity; FEF=forced mid-expiratory flow rate; FeNO=fractional exhaled nitric oxide; RV/TLC=residual volume/total lung capacity; VDP=ventilation defect percentage